Mayzent – first & only pill studied & proven in secondary progressive multiple sclerosis (SPMS).
Regina Berkovich discusses Mayzent, the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS).
835 articles
Regina Berkovich discusses Mayzent, the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS).
Patrick Connor at AstraZeneca, discusses The Lung Ambition Alliance and their goal to double the 5-year survival rate and to one day eliminate lung cancer.
Nader Sanai discusses attacking brain cancer from a completely new angle with an industry-first approach based on three key pillars.
Ostad discusses cutaneous squamous cell carcinoma (CSCC) & the survey that showed that many people are not aware of this type of skin cancer.
Greg Grunberg, an epilepsy advocate, discusses his son who suffers from drug-resistant epilepsy & the treatments he uses to control his epilepsy now.
Del Rosso discusses new data from the Phase 3b/4 ANSWER study and what this could mean for patients with severe rosacea.
Joshua Yamamoto discusses the four major advancements in the nation’s stroke prevention paradigm & his new book, “You Can Prevent A Stroke”.
Jennifer Popovsky discusses the importance of sharing good “sun sense” and understanding treatment options for those who are living with skin cancer.
Jonathan Cheng discusses the approval of KEYTRUDA as monotherapy for patients with metastatic small cell lung cancer. Learn more on Health Professional Radio.
Martin Schreiber, Chief Medical Officer for DaVita Home Dialysis, discusses kidney disease and the advancements in home dialysis care.